Chengwu Liu

Title: Chengwu Liu: Innovator in Pharmaceutical Chemistry

Introduction

Chengwu Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. With a focus on improving drug efficacy and stability, Liu has secured a total of 2 patents that showcase his innovative approach to drug development.

Latest Patents

Liu's latest patents include groundbreaking work on dominant salt forms of pyrimidine derivatives. This patent discloses sodium salts of pyrimidine derivatives along with a series of crystal forms that exhibit excellent druggability, including stability, fluidity, and compressibility. These advancements provide a variety of options for active pharmaceutical ingredients (APIs) in subsequent drug product development. Another notable patent involves the crystal form and salt form of a pyridoimidazole compound, along with its preparation method. This invention highlights the use of the crystal form in preparing anti-influenza virus drugs, showcasing Liu's commitment to addressing pressing health challenges.

Career Highlights

Chengwu Liu is currently associated with Guangdong Raynovent Biotech Co., Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work is characterized by a strong emphasis on the practical applications of his inventions, aiming to enhance the therapeutic potential of new drugs.

Collaborations

Liu collaborates with talented professionals in his field, including Xiaoxin Chen and Zhuowei Liu. These partnerships foster a dynamic environment for research and development, allowing for the exchange of ideas and expertise.

Conclusion

Chengwu Liu stands out as a key figure in pharmaceutical innovation, with a focus on developing effective drug formulations. His contributions through patents and collaborations reflect his dedication to advancing healthcare solutions.